A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment
Clinical trial NCT06088043 · COMPLETED
Trial details
- NCT number
- NCT06088043
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-06
- Primary completion
- 2025-01-22
- Enrollment
- 693
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.